Navigation Links
CareFusion Expands Infusion Pump Interoperability
Date:6/20/2012

SAN DIEGO, June 20, 2012 /PRNewswire/ -- CareFusion, a global medical device company, today announced an agreement to make bi-directional connectivity available between CareFusion's Alaris® System and Epic's electronic medical record (EMR) platform.

"This new relationship is an exciting step towards improving collaboration and connectivity between medical devices and information technology," said Darren Dworkin, senior vice president for Enterprise Information Systems and chief information officer at Cedars-Sinai Health System, a large academic medical center consistently ranked among the top hospitals in the nation. "This type of integration helps to further transform HIT into a strategic tool to drive improvements to both patient care and safety."

The companies intend to develop bi-directional capabilities to enable clinicians to remotely pre-populate infusion orders from the EMR to the Alaris® System, helping hospitals reduce the risk of harmful and costly intravenous (IV) medication errors that can occur during manual programming at the patient's bedside. This enhanced interface is being developed to help health care providers improve clinician workflow and increase efficiency by reducing manual or duplicative documentation that can occur through disparate systems.

"In the evolving health care landscape, interoperability between devices and information systems is among our customers' most critical priorities," said J.C. Kyrillos, senior vice president and general manager of CareFusion's Infusion Systems business. "This agreement with Epic builds on recent progress we have made across CareFusion to improve device interoperability and represents yet another way CareFusion helps hospitals bridge the gap between medical devices and HIT systems."

About CareFusion
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® skin prep products, MedMined® services for data mining surveillance, Nicolet™ neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 14,000 people across its global operations. More information may be found at www.carefusion.com.

(Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO)


'/>"/>
SOURCE CareFusion
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
2. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
3. AMRI Further Expands Discovery Capabilities in India
4. DATATRAK Expands CDISC Registered Solutions Provider Standards
5. The UCB-Harvard Research Alliance Expands and Moves Forward
6. CarePoint Partners Expands Coverage in Southeast
7. BHR Pharma Expands SyNAPSe® Trial into Thailand, China and Russia
8. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
9. Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
10. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
11. USANA Health Sciences Expands Award-Winning Research and Development Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 2017 , ... ProRehab Physical Therapy (PRPT) is ... therapy provider for Derby City CrossFit, effective immediately. , In addition to treating ... effectively as possible, ProRehab’s sports physical therapists will work with athletes to maximize ...
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... ... 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of ... I focus on preventative care with all my patients to alleviate possible future issues. I ... free to contact my office and my trained staff will assist you in any way ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):